Frontiers in Pharmacology
Scope & Guideline
Driving excellence in pharmacological research and education.
Introduction
Aims and Scopes
- Pharmacological Mechanisms and Drug Action:
The journal emphasizes research that elucidates the mechanisms of drug action at molecular, cellular, and systemic levels, contributing to the understanding of how drugs interact with biological systems. - Clinical Pharmacology and Therapeutics:
Publications often focus on the clinical application of pharmacological principles, including studies on drug efficacy, safety, and the pharmacokinetics and pharmacodynamics of various therapeutic agents. - Natural Products and Traditional Medicine:
There is a strong interest in exploring natural compounds and traditional herbal medicines, investigating their pharmacological effects, mechanisms of action, and potential therapeutic applications. - Pharmacogenomics and Personalized Medicine:
Research on genetic variations affecting drug metabolism and response is a significant area, promoting the development of personalized medicine approaches to optimize drug therapies. - Drug Safety and Pharmacovigilance:
The journal covers studies related to drug safety, adverse effects, and pharmacovigilance, highlighting the importance of monitoring and evaluating drug-related outcomes in clinical settings. - Innovative Drug Delivery Systems:
Research on novel drug delivery technologies, including nanoparticles and other advanced formulations, is also featured, aiming to enhance drug efficacy and reduce side effects.
Trending and Emerging
- Integrated Omics Approaches:
There is a significant rise in studies employing integrated omics methodologies (genomics, proteomics, metabolomics) to understand drug mechanisms and disease pathology, reflecting a trend towards holistic research perspectives. - Targeting the Gut Microbiome:
Research focusing on the gut microbiome's role in drug metabolism, efficacy, and disease treatment is gaining traction, highlighting its importance in personalized medicine and therapeutic outcomes. - Emerging Therapeutics and Drug Repurposing:
The journal is increasingly publishing articles on the repurposing of existing drugs for new therapeutic uses, emphasizing the potential of known compounds in treating various diseases. - Nanotechnology in Drug Delivery:
The application of nanotechnology for drug delivery systems is a rapidly growing area, with numerous studies investigating how nanoparticles can enhance the efficacy and safety of therapeutic agents. - Pharmacogenomics and Precision Medicine:
The focus on pharmacogenomics is expanding, with more research dedicated to understanding genetic influences on drug response, which is crucial for developing precision medicine strategies. - Natural Products as Therapeutic Agents:
A resurgence in interest for natural products, including herbal medicines and their bioactive components, is evident, particularly in their roles as potential candidates for innovative therapies.
Declining or Waning
- Conventional Pharmacological Approaches:
There has been a noticeable shift from traditional pharmacological studies towards more integrative and innovative methodologies, including systems biology and multi-omics approaches, reflecting a decline in purely conventional pharmacology research. - Single-Agent Drug Studies:
Research focusing solely on the effects of single-agent drugs is becoming less common, as there is a growing preference for studies that explore combination therapies and polypharmacology to address complex diseases. - Basic Pharmacology without Clinical Relevance:
Papers that do not bridge basic pharmacology with clinical applications are less frequently accepted, indicating a trend towards research that has direct implications for therapeutic practices. - Static Drug Interaction Studies:
The field is moving away from static studies of drug interactions to more dynamic models that incorporate patient-specific factors, highlighting a decline in traditional drug interaction research.
Similar Journals
INDIAN JOURNAL OF PHARMACOLOGY
Advancing pharmacological knowledge for a healthier tomorrow.INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.
International Journal of Pharmacology
Connecting Laboratory Discoveries to Clinical PracticeWelcome to the International Journal of Pharmacology, a key publication in the field of pharmacology, published by ASIAN NETWORK SCIENTIFIC INFORMATION (ANSINET). Since its inception in 2006, this journal has provided a vital platform for researchers and professionals to disseminate their findings and insights in pharmacology, toxicology, and pharmaceutics. Despite recent discontinuation in Scopus coverage, the journal's dedication to fostering scientific dialogue continues to attract contributions from esteemed scholars globally. With an **ISSN of 1811-7775** and **E-ISSN of 1812-5700**, the journal seeks to bridge the gap between laboratory research and clinical application, promoting a deeper understanding of drug actions and interactions. Although it operates under traditional access options, the relevance of its published studies to ongoing pharmacological research remains significant.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
Elevating pharmaceutical discourse in tropical regions.Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Elevating Pharmacological Research for Global ImpactThe JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
Connecting researchers and practitioners in pharmacology.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany, is a vital scholarly platform dedicated to advancing the field of pharmacology through rigorous research and innovative therapeutic strategies. Established in 1994, this journal has maintained its relevance in the evolving landscape of clinical pharmacology, achieving a Q3 rank in both general and medical pharmacology categories as of 2023. With an ISSN of 0946-1965, it is positioned as an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of drug therapy and pharmacological applications. Though it currently does not offer open access, its comprehensive scope covers a wide array of topics within pharmacology, promising to contribute significantly to scientific discussions and knowledge dissemination from 1994 to 2024. Whether you are looking for the latest studies or historical insights, the journal remains a fixture for anyone invested in the pharmacological sciences.
Chinese Journal of Natural Medicines
Bridging Tradition and Modern ScienceThe Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.
Research in Pharmaceutical Sciences
Exploring the Frontiers of Drug DevelopmentResearch in Pharmaceutical Sciences is a premier, peer-reviewed journal published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of pharmacology, toxicology, and pharmaceutics. With an impact factor that positions it in the second quartile of its category (Q2) and a respectable rank of 23 out of 80 in Scopus, this journal serves as an essential platform for researchers, professionals, and students alike, providing open access since 2015 to a wealth of pioneering studies and comprehensive reviews. Based in Mumbai, India, the journal encompasses a diverse range of topics within the pharmaceutical sciences, offering insights that address both theoretical and practical challenges in drug development and safety. As it converges from 2009 to 2024, Research in Pharmaceutical Sciences continues to be a vital source of knowledge, promoting innovation and fostering collaboration within the global scientific community.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Exploring Innovations in Drug Action and SafetyBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.
ACTA PHARMACOLOGICA SINICA
Fostering Innovation in the Pharmaceutical LandscapeACTA PHARMACOLOGICA SINICA is a premier journal in the field of pharmacology, published by the esteemed Nature Publishing Group. With a strong history since its inception in 1980, this journal is recognized for its impactful contributions to the fields of medicine and pharmacology, consistently securing a Q1 ranking in multiple relevant categories, including Pharmacology (Medical). Drawing on a robust international readership, it ranks impressively at #8 out of 272 in the specialty of Medical Pharmacology, placing it in the top 97th percentile according to Scopus data. Although currently not an open-access publication, ACTA PHARMACOLOGICA SINICA remains a vital resource for researchers, professionals, and students seeking to advance their understanding of pharmacological sciences. Its commitment to disseminating high-quality research underscores its significance in fostering innovation and exploration in the medical landscape.
BRITISH JOURNAL OF PHARMACOLOGY
Exploring the frontiers of pharmacology and toxicology.British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.